Huelsenbeck SC - Search Results

1

Distinct kinetics of (H/K/N)Ras glucosylation and Rac1 glucosylation catalysed by Clostridium sordellii lethal toxin.

Huelsenbeck SC, Klose I, Reichenbach M, Huelsenbeck J, Genth H. Huelsenbeck SC, et al. FEBS Lett. 2009 Oct 6;583(19):3133-9. doi: 10.1016/j.febslet.2009.09.006. Epub 2009 Sep 8. FEBS Lett. 2009. PMID: 19744486 Free article.

2

Inhibition of cytokinesis by Clostridium difficile toxin B and cytotoxic necrotizing factors--reinforcing the critical role of RhoA in cytokinesis.

Huelsenbeck SC, May M, Schmidt G, Genth H. Huelsenbeck SC, et al. Cell Motil Cytoskeleton. 2009 Nov;66(11):967-75. doi: 10.1002/cm.20390. Cell Motil Cytoskeleton. 2009. PMID: 19504561

3

Expression and cytoprotective activity of the small GTPase RhoB induced by the Escherichia coli cytotoxic necrotizing factor 1.

Huelsenbeck SC, Roggenkamp D, May M, Huelsenbeck J, Brakebusch C, Rottner K, Ladwein M, Just I, Fritz G, Schmidt G, Genth H. Huelsenbeck SC, et al. Int J Biochem Cell Biol. 2013 Aug;45(8):1767-75. doi: 10.1016/j.biocel.2013.05.020. Epub 2013 May 31. Int J Biochem Cell Biol. 2013. PMID: 23732113

4

Inhibition of macrophage migration by C. botulinum exoenzyme C3.

Rotsch J, Rohrbeck A, May M, Kolbe T, Hagemann S, Schelle I, Just I, Genth H, Huelsenbeck SC. Rotsch J, et al. Among authors: huelsenbeck sc. Naunyn Schmiedebergs Arch Pharmacol. 2012 Sep;385(9):883-90. doi: 10.1007/s00210-012-0764-9. Epub 2012 May 29. Naunyn Schmiedebergs Arch Pharmacol. 2012. PMID: 22644106

5

Rac1 protein signaling is required for DNA damage response stimulated by topoisomerase II poisons.

Huelsenbeck SC, Schorr A, Roos WP, Huelsenbeck J, Henninger C, Kaina B, Fritz G. Huelsenbeck SC, et al. J Biol Chem. 2012 Nov 9;287(46):38590-9. doi: 10.1074/jbc.M112.377903. Epub 2012 Sep 25. J Biol Chem. 2012. PMID: 23012366 Free PMC article.

6

Chronic heart damage following doxorubicin treatment is alleviated by lovastatin.

Henninger C, Huelsenbeck S, Wenzel P, Brand M, Huelsenbeck J, Schad A, Fritz G. Henninger C, et al. Pharmacol Res. 2015 Jan;91:47-56. doi: 10.1016/j.phrs.2014.11.003. Epub 2014 Nov 21. Pharmacol Res. 2015. PMID: 25462173

7

The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity.

Henninger C, Huelsenbeck J, Huelsenbeck S, Grösch S, Schad A, Lackner KJ, Kaina B, Fritz G. Henninger C, et al. Toxicol Appl Pharmacol. 2012 May 15;261(1):66-73. doi: 10.1016/j.taap.2012.03.012. Toxicol Appl Pharmacol. 2012. PMID: 22712078

8

Therapeutic effects of Clostridium botulinum C3 exoenzyme.

Just I, Rohrbeck A, Huelsenbeck SC, Hoeltje M. Just I, et al. Among authors: huelsenbeck sc. Naunyn Schmiedebergs Arch Pharmacol. 2011 Mar;383(3):247-52. doi: 10.1007/s00210-010-0589-3. Epub 2010 Dec 31. Naunyn Schmiedebergs Arch Pharmacol. 2011. PMID: 21193903 Review.

9

C3 peptide promotes axonal regeneration and functional motor recovery after peripheral nerve injury.

Huelsenbeck SC, Rohrbeck A, Handreck A, Hellmich G, Kiaei E, Roettinger I, Grothe C, Just I, Haastert-Talini K. Huelsenbeck SC, et al. Neurotherapeutics. 2012 Jan;9(1):185-98. doi: 10.1007/s13311-011-0072-y. Neurotherapeutics. 2012. PMID: 21866396 Free PMC article.

10

C3 peptide enhances recovery from spinal cord injury by improved regenerative growth of descending fiber tracts.

Boato F, Hendrix S, Huelsenbeck SC, Hofmann F, Grosse G, Djalali S, Klimaschewski L, Auer M, Just I, Ahnert-Hilger G, Höltje M. Boato F, et al. Among authors: huelsenbeck sc. J Cell Sci. 2010 May 15;123(Pt 10):1652-62. doi: 10.1242/jcs.066050. Epub 2010 Apr 20. J Cell Sci. 2010. PMID: 20406886

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10 results

Search Page